Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Allen

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Journal of Neurology|September 17, 2009
Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center studyBirgit Högl, Diego García-Borreguero, Ralf Kohnen, et al.
Sleep Medicine|June 5, 2007
Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndromeDiego García-Borreguero, Ralf Kohnen, Birgit Högl, et al.
Sleep Medicine|April 23, 2018
Restless legs syndrome is associated with major comorbidities in a population of Danish blood donorsMaria Didriksen, Richard P Allen, Brendan J Burchell, et al.
Sleep Medicine|December 12, 2018
Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLSDenise Sharon, Richard P Allen, Pablo Martinez-Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2007
Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG)Claudia Trenkwalder, Ralf Kohnen, Richard P Allen, et al.
The Lancet. Neurology|October 15, 2017
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysisBarbara Schormair, Chen Zhao, Steven Bell, et al.
Plos Genetics|July 23, 2011
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1Juliane Winkelmann, Darina Czamara, Barbara Schormair, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Journal of Neurology|September 17, 2009
Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center studyBirgit Högl, Diego García-Borreguero, Ralf Kohnen, et al.
Sleep Medicine|June 5, 2007
Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndromeDiego García-Borreguero, Ralf Kohnen, Birgit Högl, et al.
Sleep Medicine|April 23, 2018
Restless legs syndrome is associated with major comorbidities in a population of Danish blood donorsMaria Didriksen, Richard P Allen, Brendan J Burchell, et al.
Sleep Medicine|December 12, 2018
Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLSDenise Sharon, Richard P Allen, Pablo Martinez-Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2007
Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG)Claudia Trenkwalder, Ralf Kohnen, Richard P Allen, et al.
The Lancet. Neurology|October 15, 2017
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysisBarbara Schormair, Chen Zhao, Steven Bell, et al.
Plos Genetics|July 23, 2011
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1Juliane Winkelmann, Darina Czamara, Barbara Schormair, et al.
Pageof 19